Melbourne, Australia Seth Masters, the Walter and Eliza Hall Institute, Victoria, Australia Kate Schroder, the University of Queensland, Brisbane, Australia
Total Page:16
File Type:pdf, Size:1020Kb
Welcome The International Cytokine and Interferon Society 2014 Annual Meeting Cytokines Down Under: From Bench to Beyond 26th October – 29th October, 2014 Melbourne Convention & Exhibition Centre Dear colleagues, On behalf of the Scientific Organizing Committee, it is with great pleasure to welcome you to Melbourne to attend the second annual meeting of the International Cytokine and Interferon Society (ICIS). Specific topics will include the latest aspects on the biology, signal transduction and gene regulation of cytokines, interferons and their receptors in innate and adaptive immunity, as well as pattern recognition receptors and their role in host-pathogen interactions, infectious diseases, inflammation, cancer, autoimmunity and metabolism. Sessions will include cutting edge basic science and clinical presentations in plenary and concurrent symposia, as well as eminent keynote presentations, and are strongly supported by poster sessions and trade displays. The meeting promises to provide an outstanding forum for basic science and clinical researchers to present their latest data and exchange ideas relating to the broad role of cytokines and interferons in human disease, and applications to therapies. In addition, the meeting will provide strong networking opportunities for scientists in the biotechnology and pharmaceutical industries. We are pleased with the attendance from all over the globe by both established and new investigators and students –Thanks for your support. We thank the Society and all sponsors who have helped to make this happen. This broad attendance, will help assure a vibrant and exciting conference for all. We also note that Australia, and Melbourne in particular, is a perfect location to visit at this time of year, being in the peak of Spring. Melbourne is a vibrant and multicultural city known as the “sporting capital of Australia”, being home to the Australian Tennis Open, Australian Formula 1 Grand Prix, and the Spring Racing Carnival featuring the Melbourne Cup (first Tuesday in November), one of the largest and most prestigious horse races in the world. Together with its renowned riverside atmosphere, café culture, nearby beaches and wineries, it is no surprise Melbourne has been voted the most liveable city in the world for the 4th year in a row, with other Australian capital cities Adelaide, Sydney and Perth also featuring in the top 10. We trust you will have a most productive conference and memorable experience whilst in Australia. Brendan Jenkins and Paul Hertzog Co-convenors The International Cytokine and Interferon Society 2014 Annual Meeting - Page 1 Index Page SECTION 1 – INTRODUCTION AND DELEGATE INFORMATION Welcome 1 Contents 2 Organising Committee 3 Sponsors 4 Keynote Speakers 5 Symposia Speakers 6 2014 Award Winners 17 Delegate Information 18 Venue Map 21 Melbourne Information 22 Sponsor / Exhibitor Listing & Map 23 SECTION 2 – SCIENTIFIC PROGRAM Full Program : Sunday 28 Monday 30 Tuesday 35 Wednesday 39 SECTION 3 – PRESENTING AUTHOR INDEX 43 SECTION 4 – ABSTRACTS Speaker Abstracts 67 Meeting Abstracts 70 SECTION 5 – DELEGATE LIST 138 The International Cytokine and Interferon Society 2014 Annual Meeting - Page 2 Organising Committee Convenors Secretariat Paul Hertzog, MIMR-PHI Institute of Medical Research, Maree Overall, ASN Events Pty Ltd Victoria, Australia Kara Taglieri, ASN Events Pty Ltd Brendan Jenkins, MIMR-PHI Institute of Medical Research, Victoria, Australia Local Organising Committee Iain Campbell, University of Sydney, NSW, Australia Angel Lopez, Centre for Cancer Biology, SA, Australia Ashley Mansell, MIMR-PHI Institute of Medical Research, Victoria, Australia Sandra Nicholson, Walter and Eliza Hall Institute of Medical Research, Victoria, Australia Matt Sweet, Institute for Molecular Bioscience, Queensland, Australia International Scientific Advisory Committee Vishva Dixit, Research Genentech, Inc., United States Eleanor Fish, University Health Network, Canada Sarah Gaffen, University of Pittsburgh, United States Simon Jones, Cardiff University, United Kingdom Doug Hilton, Walter and Eliza Hall Institute of Medical Research, Australia Hong Tang, Chinese Academy of Sciences, China Luke O’Neill, Trinity College Dublin, Ireland Masanobu Oshima, Kanzawa University, Japan. Leon Platanias, Robert H. Lurie Comprehensive Cancer Center, United States Stefan Rose-John, University of Kiel, Germany Bryan Williams, MIMR-PHI Institute of Medical Research, Australia Howard Young, National Cancer Institute at Frederick, United States The International Cytokine and Interferon Society 2014 Annual Meeting - Page 3 Sponsors The Organising Committee for the International Cytokine & Interferon Society 2014 Meeting acknowledges with gratitude, the generous support received from the following sponsors: GOLD SPONSORS SILVER SPONSORS BRONZE SPONSORS SPONSORS The International Cytokine and Interferon Society 2014 Annual Meeting - Page 4 Keynote Speakers Peter Doherty, University of Melbourne Professor Peter Doherty shared the Nobel Prize in Physiology or Medicine in 1996 with Swiss colleague Rolf Zinkernagel, for their discovery of how the immune system recognises virus-infected cells. He was Australian of the Year in 1997, and has since been commuting between St Jude Children’s Research Hospital in Memphis and the Department of Microbiology and Immunology at the University of Melbourne. His research is mainly in the area of defence against viruses. He regularly devotes time to delivering public lectures, writing articles for newspapers and magazines and participating in radio discussions. Peter Doherty graduated from the University of Queensland in Veterinary Science and became a veterinary officer. Moving to Scotland, he received his PhD from the University of Edinburgh Medical School. He is the first person with a veterinary qualification to win a Nobel Prize. Peter is also the author of several books, including “A Light History of Hot Air”, “The Beginners Guide to Winning the Nobel Prize” and "Sentinel Chickens: What birds tell us about our health and the world". Nicos Nicola, Walter and Eliza Hall Institute of Medical Research Dr. Nicola’s laboratory has focused on the molecular regulation of haemopoietic cell production and function for over 30 years. A major emphasis has been on the cytokines that regulate the production and functional activation of granulocytes and macrophages, two types of white blood cells that co-ordinate innate immune responses to bacterial and viral infections. His work has led to the identification, purification and/or molecular cloning of several important cytokines (G-CSF, GM-CSF and leukaemia inhibitory factor (LIF)), the identification and molecular cloning of several cytokine receptors (including the GM-CSF, interleukin-11 and interleukin-13 receptors) and the identification of a new family of inducible, intracellular inhibitors of these cytokine/receptor signaling pathways. These suppressors of cytokine signaling (SOCS) proteins have been shown to have crucial roles in vivo in limiting the extent and duration of responses to various cytokines thus preventing excessive inflammatory and autoimmune responses. He is also investigating the role of cytokines and cytokine signaling pathways in the development and maintenance of leukaemic cell populations and the usefulness of cytokines or cytokine antagonists as therapies or adjunct therapies in cancer treatments. Luke O’Neill, Trinity College Dublin The major focus of the group is to provide a molecular understanding of innate immunity and inflammation. We are interested in receptors involved in innate immunity, such as Toll-like receptors (TLRs) and Nod-like receptors (NLRs – including Nlrp3), and also signals activated, including NF-kappaB, IRF family transcription factors and MAP kinases. The role played by this system in inflammatory diseases is also under investigation. We have several projects underway including – Role of the adapter Mal in the epithelial barrier in the gut, Control of TLRs and NLRs by microRNAs, Role of Nlrp3 in Type 2 diabetes, Novel proteins in the TLR and NLR systems, The role of Btk in TLR signalling, The control of trafficking of TLR4, Genetic variation in innate immune genes and inflammatory diseases, Role of IL-36 in inflammation. The International Cytokine and Interferon Society 2014 Annual Meeting - Page 5 Symposia Speakers Shizuo Akira, Osaka University Shizuo Akira is a director and professor of WPI Immunology Frontier Research Center, and also a professor in Institute for Microbial Diseases at Osaka University, Japan. He received his M.D. and Ph.D. from Osaka University. After two years of postdoctoral working in Department of Immunology, University of California at Berkeley, he started to study on IL-6 gene regulation and signaling in the Institute for Molecular and Cellular Biology, Osaka University, and cloned transcription factors, NF-IL6(C/EBP beta) and STAT3. He was a professor in Department of Biochemistry, Hyogo College of Medicine from 1996 to 1999, where he became involved in Toll-like receptors research. By generating TLR family knockout mice, he identified ligands of many TLR members. He also demonstrated that the difference in signaling pathway among TLRs is due to selective usage of adaptor molecules such as MyD88 and TRIF. He demonstrated that pathogen-derived RNA is recognized by cytoplasmic receptor family, besides TLRs, and clarified the molecular mechanism of antiviral response against RNA viruses. His current research interests are molecular mechanisms